Anhui Anke Biotechnology (Group) Co (SZSE:300009) Dividend-Payout-to-FFO


SZSE:300009 Anhui Anke Biotechnology (Group) Co Ltd SZSE:300009
85 GF Score
Price ¥7.86
GF Value ¥10.16
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Anhui Anke Biotechnology (Group) Co Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.

SZSE:300009
85GF Score
Anhui Anke Biotechnology (Group) Co Ltd SZSE:300009
Dividend-Payout-to-FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Anhui Anke Biotechnology (Group) Co (SZSE:300009) Overvalued in 2026?

Based on GuruFocus' analysis, Anhui Anke Biotechnology (Group) Co stock appears to be undervalued. The current stock price of ¥7.86 is trading 22.6% below its estimated GF Value™ of ¥10.16. GuruFocus considers Anhui Anke Biotechnology (Group) Co to be Modestly Undervalued.

Key valuation signals for SZSE:300009:

  • Dividend-Payout-to-FFO:
  • GF Value™: ¥10.16 vs. price of ¥7.86 (22.6% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the SZSE:300009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Anhui Anke Biotechnology (Group) Co Business Description

Address No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.
85GF Score

Get the complete analysis for SZSE:300009

Dividend-Payout-to-FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.86
Price
¥10.16
GF Value